• Via Della Cooperazione – Medicina (BO) Italy
  • +39 051 6970791
  • info@polycrystalline.it
  • CONTACT US
  • CARRERS
Polycrystalline Polycrystalline
  • Company
  • Services
  • CDMO Division
  • CrystalForms@BO
  • News
PREVIOUS

FRENCH CERTIFICATION

Minodronic Acid novel form

  • Home
  • News
NEXT

Highly Potent API

  • Popular
  • Recent
  • Polymorphs of Dex-Lansoprazole
  • Des-Methyl-Venlafaxine Salt
  • Minodronic Acid novel form
  • Highly Potent API
  • GMP CERTIFICATION
  • FRENCH CERTIFICATION
  • IMAZAMOX: A Quest for Polymorphic Modifications of a Chiral and Racemic Herbicid
  • MyCrystalPro: Our Online Portal
  • Controlled Substances Studies & Analysis
  • MyCrystalPro: Our Online Portal
  • Pipeline services
  • FDA - GMP
  • CF@BO 2021, September 10 - 11
  • Sostanze Altamente Attive: Rischi E Contenimento
  • Meet us at DCAT in New York!
  • Meet us at DCAT in New York!
  • Controlled Substances Studies & Analysis
  • MyCrystalPro: Our Online Portal
  • MyCrystalPro: Our Online Portal
  • Highly Potent API

PolyCrystalLine discovered a novel crystalline form of Minodronic Acid and filed a patent application.

For additional information contact info@polycrystalline.it


Share
  • Company
  • Services
  • CDMO Division
  • CrystalForms@BO
  • News
CONTACT US

(+39) 051 6970791

info@polycrystalline.it

Polycrystalline Website

© Copyright Polycrystalline SpA - All rights reserved - VAT IT02600021204